Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1991 1
1995 3
1996 1
2001 3
2004 3
2008 3
2009 5
2010 3
2011 1
2012 1
2013 1
2014 1
2015 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Uncommon EGFR Mutations in Non-Small Cell Lung Cancer and Their Impact on the Treatment.
Bílek O, Holánek M, Berkovcová J, Horký O, Kazda T, Čoupková H, Špelda S, Kristková L, Zvaríková M, Podhorec J, Bořilová S, Bohovicová L, Zdražilová Dubská L. Bílek O, et al. Among authors: spelda s. Klin Onkol. 2019 Fall;32(Supplementum 3):6-12. doi: 10.14735/amko20193S6. Klin Onkol. 2019. PMID: 31627700 Review. English.
[The TULUNG clinical registry].
Spelda S, Skřičková J, Bortlíček Z, Hejduk K, Pešek M, Zatloukal P, Kolek V, Salajka F, Koubková L, Tomíšková M, Grygárková Y, Havel L, Hrnčiarik M, Zemanová M, Sixtová D, Roubec J, Coupková H, Košatová K. Spelda S, et al. Klin Onkol. 2012;25(5):383-4. Klin Onkol. 2012. PMID: 23102201 Czech. No abstract available.
Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.
Rudin CM, Mauer A, Smakal M, Juergens R, Spelda S, Wertheim M, Coates A, McKeegan E, Ansell P, Zhou X, Qian J, Pradhan R, Dowell B, Krivoshik A, Gordon G. Rudin CM, et al. Among authors: spelda s. J Clin Oncol. 2011 Mar 10;29(8):1075-82. doi: 10.1200/JCO.2010.32.5944. Epub 2011 Feb 7. J Clin Oncol. 2011. PMID: 21300929 Free PMC article. Clinical Trial.
[Treatment of non small cell lung cancer].
Skricková J, Coupek P, Babicková L, Tomísková M, Kaplanová J, Princ D, Kadlec B, Spelda S. Skricková J, et al. Among authors: spelda s. Klin Onkol. 2008;21(6):317-29. Klin Onkol. 2008. PMID: 19382595 Review. Czech.
Different solutions used for submucosal injection influenced early healing of gastric endoscopic mucosal resection in a preclinical study in experimental pigs.
Bures J, Kopácová M, Kvetina J, Osterreicher J, Sinkorová Z, Svoboda Z, Tachecí I, Filip S, Spelda S, Kunes M, Rejchrt S. Bures J, et al. Among authors: spelda s. Surg Endosc. 2009 Sep;23(9):2094-101. doi: 10.1007/s00464-008-0207-3. Epub 2008 Dec 5. Surg Endosc. 2009. PMID: 19057952 Free PMC article.
26 results